Cutler Group LP Chroma Dex Corp. Call Options Transaction History

Cutler Group LP

11 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2021 Oct 26, 2021	SELL	$6.05 - $10.41 $81,070 - $139,494	-13,400 Reduced 79.29%	3,500 $0
Q2 2021 Jul 19, 2021	SELL	$6.66 - $10.92 $73,260 - $120,120	-11,000 Reduced 39.43%	16,900 $10,000
Q1 2021 Apr 26, 2021	BUY	$4.59 - $18.74 $100,980 - $412,279	22,000 Added 372.88%	27,900 $33,000
Q4 2020 Jan 21, 2021	BUY	$3.93 - $5.5 $21,222 - $29,700	5,400 Added 1080.0%	5,900 $4,000
Q2 2020 Jul 22, 2020	BUY	$3.0 - $5.52 $1,500 - $2,760	500 New	500 $0
Q1 2019 May 10, 2019	SELL	$3.2 - $4.19 $12,160 - $15,922	-3,800 Closed	0 $0
Q4 2018 Feb 05, 2019	BUY	$2.8 - $4.22 $10,640 - $16,035	3,800 New	3,800 $0
Q3 2018 Nov 07, 2018	SELL	$3.5 - $4.91 $17,850 - $25,041	-5,100 Closed	0 $0
Q2 2018 Aug 10, 2018	SELL	$3.22 - $4.43 $7,084 - $9,746	-2,200 Reduced 30.14%	5,100 $1,000
Q1 2018 May 11, 2018	BUY	$4.05 - $6.46 $27,540 - $43,928	6,800 Added 1360.0%	7,300 $1,000
Q4 2017 Jan 17, 2018	BUY	$3.88 - $6.96 $1,940 - $3,480	500	500 $0

17.2M

66.7K

8.2K

Ticker CDXC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,350,896
Market Cap $510M
Description
ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.